Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session: Tyrosine Kinase Alterations and Response to Therapy

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Predicting Clinical Activity to Lapatinib: Beyond ErbB2(Her2)
Anne-Marie Martin, Ph.D.
GlaxoSmithKline, Collegeville, PA
from 2007 Molecular Diagnostics in Cancer Therapeutic Development conference on September 18, 2007 4:30 PM-6:45 PM
Personalized Therapy Options for Advanced Non-Small Cell Lung Cancer
Roy S. Herbst, M.D., Ph.D.
UT M. D. Anderson Cancer Center, Houston, TX
from 2007 Molecular Diagnostics in Cancer Therapeutic Development conference on September 18, 2007 4:30 PM-6:45 PM
A Systems Biology Approach to Molecular Diagnostics in the EGFR/HER2 System
Yosef Yarden, Ph.D.
Weizmann Inst. of Science, Rehovot, Israel
from 2007 Molecular Diagnostics in Cancer Therapeutic Development conference on September 18, 2007 4:30 PM-6:45 PM
Detection of BCR/ABL T3151 Mutations in Cancer and Response to TKI Therapy
Dr. David Whitcombe
DxS Ltd., Manchester, UK
from 2007 Molecular Diagnostics in Cancer Therapeutic Development conference on September 18, 2007 4:30 PM-6:45 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4